Page last updated: 2024-08-21

indazoles and Rhinitis

indazoles has been researched along with Rhinitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beerahee, M; Cahn, A; Graves, R; Hall, D; Hodgson, S; Hughes, SC; Robertson, J; Solari, R; van Marle, S; Watson, J; Wilson, R; Young, G	1

Trials

1 trial(s) available for indazoles and Rhinitis

Article	Year
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study. BMC pharmacology & toxicology, 2013, Feb-28, Volume: 14 Topics: Abdominal Pain; Administration, Oral; Adult; Aged; Area Under Curve; Biological Availability; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Headache; Humans; Indazoles; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Receptors, CCR4; Rhinitis; Sulfonamides; Young Adult	2013

Article

Year

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study.

BMC pharmacology & toxicology, 2013, Feb-28, Volume: 14

Topics: Abdominal Pain; Administration, Oral; Adult; Aged; Area Under Curve; Biological Availability; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Headache; Humans; Indazoles; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Receptors, CCR4; Rhinitis; Sulfonamides; Young Adult

2013